A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease-Reference-Cited by-同舟云学术

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

Published:2015-03-17 Issue:10 Volume:41 Page:980-990
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Eaton J. E.¹,Juran B. D.¹,Atkinson E. J.²,Schlicht E. M.¹,Xie X.²,de Andrade M.²,Lammert C. S.³,Luketic V. A.⁴,Odin J. A.⁵,Koteish A. A.⁶,Kowdley K. V.⁷,Chopra K. B.⁸,Hirschfield G. M.⁹,Chalasani N. P.³,Lazaridis K. N.¹

Affiliation:

1. Division of Gastroenterology & Hepatology; Mayo Clinic; Rochester MN USA

2. Division of Biomedical Statistics and Informatics; Mayo Clinic; Rochester MN USA

3. Department of Medicine; Indiana University School of Medicine; Indianapolis IN USA

4. Gastroenterology and Hepatology Section; Virginia Commonwealth University; Richmond VA USA

5. Department of Medicine; The Mount Sinai School of Medicine; New York NY USA

6. Department of Medicine; Johns Hopkins University School of Medicine; Baltimore MD USA

7. Liver Care Network; Swedish Medical Center; Seattle WA USA

8. Division of Gastroenterology, Hepatology and Nutrition; University of Pittsburgh; Pittsburgh PA USA

9. Centre for Liver Research and NIHR Biomedical Research Unit; University of Birmingham; Birmingham UK

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13154/fullpdf

Reference46 articles.

1. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management;Eaton;Gastroenterology,2013

2. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis;Karlsen;Aliment Pharmacol Ther,2014

3. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

4. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community;Bambha;Gastroenterology,2003

5. An update on the epidemiology of inflammatory bowel disease in Asia;Thia;Am J Gastroenterol,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal deoxycholic acid associates with diet, intestinal microbes and total bilirubin in primary sclerosing cholangitis;JHEP Reports;2024-08

2. Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval;Journal of Autoimmunity;2024-07

3. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts;Gastroenterology;2024-06

4. Primary Sclerosing Cholangitis;Clinics in Liver Disease;2024-02

5. Primary sclerosing cholangitis and IgG4-associated cholangitis;The Rose and Mackay Textbook of Autoimmune Diseases;2024